The Scientist

» protein structure and microbiology

Most Recent

image: Screening Goes In Silico

Screening Goes In Silico

By | February 1, 2015

Computational tools take some of the cost—and guesswork—out of drug discovery.

0 Comments

image: Stubbornly Persistent

Stubbornly Persistent

By | February 1, 2015

Computational tools take some of the cost—and guesswork—out of drug discovery.

1 Comment

image: The Energy of Life

The Energy of Life

By | February 1, 2015

Computational tools take some of the cost—and guesswork—out of drug discovery.

3 Comments

image: UV Light Doesn’t Fully Purify

UV Light Doesn’t Fully Purify

By | January 28, 2015

Computational tools take some of the cost—and guesswork—out of drug discovery.

0 Comments

image: GMO “Kill Switches”

GMO “Kill Switches”

By | January 21, 2015

Computational tools take some of the cost—and guesswork—out of drug discovery.

6 Comments

image: Picturing Infection

Picturing Infection

By | January 1, 2015

Computational tools take some of the cost—and guesswork—out of drug discovery.

4 Comments

image: Measuring DNA with a Smartphone

Measuring DNA with a Smartphone

By | December 23, 2014

Computational tools take some of the cost—and guesswork—out of drug discovery.

0 Comments

image: Imagining a “World Without Microbes”

Imagining a “World Without Microbes”

By | December 18, 2014

Computational tools take some of the cost—and guesswork—out of drug discovery.

0 Comments

image: Microbes Could Help Solve Sex Crimes

Microbes Could Help Solve Sex Crimes

By | December 17, 2014

Computational tools take some of the cost—and guesswork—out of drug discovery.

0 Comments

image: Gene Jumped to All Three Domains of Life

Gene Jumped to All Three Domains of Life

By | December 1, 2014

Computational tools take some of the cost—and guesswork—out of drug discovery.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech